Conmed to Acquire Endoscopic Line from Bard

In a move to complement its own electrosurgery product line, Conmed Corp. (Utica, NY, USA) has agreed to acquire certain assets of the Endoscopic Technologies business of C.R. Bard (Murray Hill, NJ, USA) for U.S.$80 million.

The business to be acquired consists of a comprehensive line of single-use medical devices employed by gastrointestinal (GI) and pulmonary doctors to diagnose and treat diseases of the digestive tract and lungs, using minimally invasive endoscopic techniques. This endoscopic product line will continue to operate from Billerica (MA, USA). Manufacturing will be moved from Bard facilities to various Conmed facilities during the transition period. The sales force will transition to Conmed and will continue to represent the product line. Conmed specializes in surgical devices and instruments for a wide range of specialties.

"We believe the combined marketing of these gastrointestinal products with our electrosurgery product line creates a competitive and unique synergistic offering,” commented Joseph C. Corasanti, president and CEO of Conmed. "We are already familiar with the gastroenterology department in hospitals because our electrosurgery products are routinely used in GI therapeutic procedures, and we look forward to greater participation in the attractive gastrointestinal and pulmonary markets.”





Related Links:
Conmed
C.R. Bard